臓器保存ソリューションの世界市場レポート 2025年

臓器保存ソリューション市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.4％で、4,525億9,000万米ドルに成長します。予測期間の成長は、拡大基準臓器に対する需要の高まり、臓器調達プログラムの拡大、臓器の品質と機能性の重視、臓器不足に対処するための世界の取り組みに起因すると考えられます。予測期間の主な動向としては、臓器バンクにおける保存ソリューションの応用、保存時間の延長に対する市場の重点化、保存強化のための添加物の統合、携帯可能でコンパクトな臓器保存デバイスへの注力、臓器保存における研究と技術革新のための協力などが挙げられます。

予想される臓器移植の急増は、今後数年間の臓器保存ソリューション市場の成長を牽引するものと思われます。臓器移植は、ドナーからレシピエントへの臓器や組織の抽出と移植を伴う外科的処置であり、臓器保存ソリューションに依存して、輸送や保管中の損傷を緩和し、それによって移植を成功させるための臓器の生存能力を高める。例えば、2023年1月の臓器調達・移植ネットワーク（OPTN）のデータによると、2022年の臓器移植件数は3.7％増加し、2021年の41,354件に比べ42,887件となりました。腎臓移植は25,000件と大きな割合を占め、米国では3.4％の伸びを示しました。その結果、臓器移植の増加は臓器保存ソリューション市場の主要促進要因となっています。

臓器保存ソリューション市場の成長は、ヘルスケア支出の増加によって推進されています。この用語は、特定の地域、国、組織内のヘルスケア部門に割り当てられた総財源を指します。ヘルスケア支出は、臓器移植手術の成功率を高めるために臓器保存ソリューションを採用しています。これらのソリューションは、輸送中や保管中に臓器を保存し、移植のための生存性を確保するために不可欠です。臓器保存ソリューションへの投資は、臓器移植の成果を向上させ、ひいては追加移植の必要性を減らし、関連する医療費を削減することにつながります。例えば、2023年11月、カナダを拠点とする団体であるカナダ健康情報研究所は、2023年のカナダの総医療費は3,440億米ドルに達し、一人当たり8,740米ドルになると予測しました。これは、2022年の伸び率がわずか1.5％であった前年と比較すると2.8％の増加であり、ヘルスケア投資の大幅な回復を浮き彫りにしています。したがって、ヘルスケア支出の増加が、今後数年間の臓器保存ソリューション市場の成長を牽引することになります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の臓器保存ソリューションPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の臓器保存ソリューション市場：成長率分析
• 世界の臓器保存ソリューション市場の実績：規模と成長, 2019-2024
• 世界の臓器保存ソリューション市場の予測：規模と成長, 2024-2029, 2034F
• 世界の臓器保存ソリューション総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の臓器保存ソリューション市場：ソリューションタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビアスパン
• カストジオール-HTK（ヒスチジン-トリプトファン-ケトグルタル酸）
• レノグラフ
• 低体温症
• パーファデックス
• リフォー
• HBS（高浸透圧血液代替物）溶液
• siRNA（低分子干渉RNA）移植ソリューション
• その他のソリューションタイプ
• 世界の臓器保存ソリューション市場：臓器タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腎臓
• 肝臓
• 肺
• 心臓
• その他の臓器の種類
• 世界の臓器保存ソリューション市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 静的冷蔵（SCS）技術
• 低体温マシン灌流
• その他のテクニック
• 世界の臓器保存ソリューション市場、タイプ別サブセグメンテーション：ビアスパン、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準ビアスパン
• 改良ビアスパン処方
• 世界の臓器保存ソリューション市場、タイプ別サブセグメンテーション：カストジオール-HTK（ヒスチジン-トリプトファン-ケトグルタル酸）、実績と予測, 2019-2024, 2024-2029F, 2034F
• カストジオール製剤
• 添加物を含む変種
• 世界の臓器保存ソリューション市場、タイプ別サブセグメンテーション：レノグラフ、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腎臓保存のためのレノグラフソリューション
• 特殊レノグラフ処方
• 世界の臓器保存ソリューション市場、タイプ別サブセグメンテーション：低体温症、実績と予測, 2019-2024, 2024-2029F, 2034F
• さまざまな臓器のための低体温剤
• カスタム低体温剤ミックス
• 世界の臓器保存ソリューション市場、タイプ別サブセグメンテーション：Perfadex、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肺保存のためのパーファデックス
• 適応型Perfadex処方
• 世界の臓器保存ソリューション市場、タイプ別サブセグメンテーション：Lifor、実績と予測, 2019-2024, 2024-2029F, 2034F
• 多臓器保存のためのLifor
• 特定のLifor適応
• 世界の臓器保存ソリューション市場、タイプ別サブセグメンテーション：HBS（高浸透圧血液代替物）ソリューション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臓器輸送のためのHBS
• 特殊HBS製剤
• 世界の臓器保存ソリューション市場、タイプ別サブセグメンテーション：siRNA（低分子干渉RNA）移植ソリューション、実績と予測, 2019-2024, 2024-2029F, 2034F
• siRNAベースの保存方法
• siRNAアプリケーションにおけるイノベーション
• 世界の臓器保存ソリューション市場、タイプ別サブセグメンテーション：その他のソリューションタイプ、実績と予測, 2019-2024, 2024-2029F, 2034F
• 実験的な保存ソリューション
• 新たな臓器保存技術

第7章 地域別・国別分析

• 世界の臓器保存ソリューション市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の臓器保存ソリューション市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 臓器保存ソリューション市場：競合情勢
• 臓器保存ソリューション市場：企業プロファイル
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Accord Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • BioLife Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Lifeline Scientific Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• TransMedics Group Inc.
• XVIVO Perfusion AB
• Organ Recovery Systems Inc.
• Bridge to Life Ltd.
• Paragonix Technologies Inc.
• OrganOx Limited
• Shanghai Genext Pharmaceutical Technology
• 21st Century Medicine
• Institut Georges Lopez
• Carnamedica
• Global Transplant Solutions
• Preservation Solutions Inc.
• Essential Pharmaceuticals LLC
• Dr. Franz Kohler Chemie GmbH
• Advanced Organ Preservation Solutions（OPSL Group）

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 臓器保存ソリューション市場2029：新たな機会を提供する国
• 臓器保存ソリューション市場2029：新たな機会を提供するセグメント
• 臓器保存ソリューション市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Organ preservation solutions are specially formulated solutions designed for the preservation of organs during transplantation or storage. These solutions play a crucial role in safeguarding organs from potential damage during the transplantation process and extending the period for which organs can be stored outside of the body. Organ preservation solutions are formulated with specific agents that aim to mitigate ischemia-reperfusion injury (IRI) by employing targeted mechanisms of action.

There are several main types of organ preservation solutions, including Viaspan, Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), Renograf, Hypothermosol, Perfadex, Lifor, HBS (Hyperosmotic Blood Substitute) Solution, siRNA (Small Interfering RNA) Transplant Solutions, and others. Viaspan, for example, is utilized for the cold storage preservation of solid organs such as the liver, pancreas, and kidneys. It plays a crucial role in maintaining organ viability during transportation and before transplantation. These solutions are employed in preserving various organs, including kidneys, liver, lungs, hearts, and others, utilizing techniques such as static cold storage (SCS) and hypothermic machine perfusion. These preservation techniques are essential for ensuring the successful transplantation of organs and improving overall patient outcomes.

The organ preservation solution research report is one of a series of new reports from The Business Research Company that provides organ preservation solution market statistics, including the organ preservation solution industry's global market size, regional shares, competitors with an organ preservation solution market share, detailed organ preservation solution market segments, market trends and opportunities, and any further data you may need to thrive in the organ preservation solution industry. This organ preservation solution market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The organ preservation solution market size has grown strongly in recent years. It will grow from $293.99 billion in 2024 to $316.01 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to a rise in organ transplants, growing awareness of organ donation, expansion of healthcare infrastructure, and increasing incidence of organ failure

The organ preservation solution market size is expected to see strong growth in the next few years. It will grow to $452.59 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rising demand for extended criteria organs, expansion of organ procurement programs, focus on organ quality and functionality, and global initiatives to address organ shortage. Major trends in the forecast period include the application of preservation solutions in organ banking, market emphasis on extended preservation times, integration of additives for enhanced preservation, focus on portable and compact organ preservation devices, and collaborations for research and innovation in organ preservation.

The anticipated surge in organ transplantation is poised to drive the growth of the organ preservation solution market in the coming years. Organ transplantation, a surgical procedure involving the extraction and transfer of organs or tissues from a donor to a recipient, relies on organ preservation solutions to mitigate damage during transportation and storage, thereby enhancing organ viability for successful transplantation. For instance, data from the Organ Procurement and Transplantation Network (OPTN) in January 2023 revealed a 3.7 percent increase in organ transplants in 2022, totaling 42,887 procedures compared to 41,354 in 2021. Kidney transplants, constituting a significant share with 25,000 procedures, exhibited a 3.4 percent growth in the United States. Consequently, the upswing in organ transplantation is a key driver for the organ preservation solution market.

The growth of the organ preservation solution market is being propelled by rising healthcare spending. This term refers to the total financial resources allocated to the healthcare sector within a specific region, country, or organization. Healthcare spending employs organ preservation solutions to enhance the success rates of organ transplantation procedures. These solutions are essential for preserving organs during transportation and storage, ensuring their viability for transplantation. Investing in organ preservation solutions leads to improved outcomes for organ transplants, which in turn can reduce the need for additional transplantations and lower associated healthcare costs. For instance, in November 2023, the Canadian Institute for Health Information, a Canada-based organization, projected that total health spending in Canada would reach $344 billion in 2023, which amounts to $8,740 per person. This represents a 2.8% increase compared to the previous year, which saw a growth rate of only 1.5% in 2022, highlighting a significant rebound in healthcare investment. Therefore, the increase in healthcare spending is driving the growth of the organ preservation solution market in the coming years.

Product innovation is a significant trend gaining traction in the organ preservation solution market. Leading companies in this sector are concentrating on developing cutting-edge products to enhance their position and secure a competitive edge. For example, in June 2024, Paragonix Technologies, a US-based firm specializing in organ preservation technology, introduced the PancreasPak Organ Preservation System. This device is the first to receive FDA clearance specifically designed to protect and monitor donor pancreases during transportation, underscoring its crucial role in organ transplantation. The system creates a controlled environment that maintains the pancreas at an optimal thermal range of 4-8°C, which is vital for preserving the organ's viability and functionality during transport, which can last up to 21 hours. The PancreasPak is also equipped with digital monitoring capabilities that continuously track the temperature and surrounding conditions of the pancreas. This real-time data facilitates immediate action in response to any deviations from optimal conditions, thereby enhancing organ preservation.

Moreover, major companies in the organ preservation solution market are actively pursuing technological advancements, particularly in the realm of organ tracking technology, as a strategic move to enhance their competitive standing in organ transportation. Organ tracking technology involves a spectrum of tools and systems dedicated to monitoring the location and condition of organs during transit. In October 2022, Paragonix Technologies Inc. unveiled its VantagePoint organ tracking technology, providing real-time tracking capabilities for donor organs in transit. This technology aims to enhance transparency and accountability in donor organ transportation, augmenting the digital tracking capabilities offered by the Paragonix App.

In September 2024, Getinge, a Sweden-based medical technology firm, acquired Paragonix Technologies for $253 million. This acquisition enables Getinge to enter the fast-growing organ preservation and transportation market, which is witnessing substantial growth driven by rising transplant volumes and technological advancements. Paragonix Technologies is a US-based biotechnology company specializing in organ preservation solutions.

Major companies operating in the organ preservation solution market include Bristol-Myers Squibb Company, Baxter International Inc., Accord Healthcare, BioLife Solutions Inc., Lifeline Scientific, TransMedics Group Inc., XVIVO Perfusion AB, Organ Recovery Systems Inc., Bridge to Life Ltd., Paragonix Technologies Inc., OrganOx Limited, Shanghai Genext Pharmaceutical Technology, 21st Century Medicine, Institut Georges Lopez, Carnamedica, Global Transplant Solutions, Preservation Solutions Inc., Essential Pharmaceuticals LLC, Dr. Franz Kohler Chemie GmbH, Advanced Organ Preservation Solutions (OPSL Group), Vascular Perfusion Solutions Inc., Transplant Biomedicals SL

North America was the largest region in the organ preservation solution market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organ preservation solution market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the organ preservation solution market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The organ preservation solution market consists of sales of the histidine-tryptophan-ketoglutarate solution and hypertonic citrate adenine solution. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Organ Preservation Solution Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on organ preservation solution market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for organ preservation solution ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The organ preservation solution market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Solution Type: Viaspan; Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate); Renograf; Hypothermosol; Perfadex; Lifor; HBS (Hyperosmotic Blood Substitute) Solution; siRNA (Small Interfering RNA) Transplant Solutions; Other Solution Types
• 2) By Organ Type: Kidneys; Liver; Lung; Heart; Other Organ Types
• 3) By Technique: Static Cold Storage (SCS) Technique; Hypothermic Machine Perfusion; Other Techniques
• Subsegments:
• 1) By Viaspan: Standard Viaspan; Modified Viaspan Formulations
• 2) By Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate): Custodiol Formulations: Variants With Additives
• 3) By Renograf: Renograf Solutions For Kidney Preservation; Specialty Renograf Formulations
• 4) By Hypothermosol: Hypothermosol For Various Organs; Custom Hypothermosol Mixes
• 5) By Perfadex: Perfadex For Lung Preservation; Adapted Perfadex Formulations
• 6) By Lifor: Lifor For Multi-Organ Preservation; Specific Lifor Adaptations
• 7) By HBS (Hyperosmotic Blood Substitute) Solution: HBS For Organ Transport; Specialty HBS Formulations
• 8) By siRNA (Small Interfering RNA) Transplant Solutions: siRNA-Based Preservation Methods; Innovations In siRNA Applications
• 9) By Other Solution Types: Experimental Preservation Solutions; Emerging Organ Preservation Technologies
• Companies Mentioned: Bristol-Myers Squibb Company; Baxter International Inc.; Accord Healthcare; BioLife Solutions Inc.; Lifeline Scientific
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Organ Preservation Solution Market Characteristics

3. Organ Preservation Solution Market Trends And Strategies

4. Organ Preservation Solution Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Organ Preservation Solution Growth Analysis And Strategic Analysis Framework

• 5.1. Global Organ Preservation Solution PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Organ Preservation Solution Market Growth Rate Analysis
• 5.4. Global Organ Preservation Solution Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Organ Preservation Solution Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Organ Preservation Solution Total Addressable Market (TAM)

6. Organ Preservation Solution Market Segmentation

• 6.1. Global Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viaspan
• Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate)
• Renograf
• Hypothermosol
• Perfadex
• Lifor
• HBS (Hyperosmotic Blood Substitute) Solution
• siRNA (Small Interfering RNA) Transplant Solutions
• Other Solution Types
• 6.2. Global Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kidneys
• Liver
• Lung
• Heart
• Other Organ Types
• 6.3. Global Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Static Cold Storage (SCS) Technique
• Hypothermic Machine Perfusion
• Other Techniques
• 6.4. Global Organ Preservation Solution Market, Sub-Segmentation Of Viaspan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Viaspan
• Modified Viaspan Formulations
• 6.5. Global Organ Preservation Solution Market, Sub-Segmentation Of Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Custodiol Formulations
• Variants With Additives
• 6.6. Global Organ Preservation Solution Market, Sub-Segmentation Of Renograf, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Renograf Solutions For Kidney Preservation
• Specialty Renograf Formulations
• 6.7. Global Organ Preservation Solution Market, Sub-Segmentation Of Hypothermosol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypothermosol For Various Organs
• Custom Hypothermosol Mixes
• 6.8. Global Organ Preservation Solution Market, Sub-Segmentation Of Perfadex, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Perfadex For Lung Preservation
• Adapted Perfadex Formulations
• 6.9. Global Organ Preservation Solution Market, Sub-Segmentation Of Lifor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lifor For Multi-Organ Preservation
• Specific Lifor Adaptations
• 6.10. Global Organ Preservation Solution Market, Sub-Segmentation Of HBS (Hyperosmotic Blood Substitute) Solution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• HBS For Organ Transport
• Specialty HBS Formulations
• 6.11. Global Organ Preservation Solution Market, Sub-Segmentation Of siRNA (Small Interfering RNA) Transplant Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• siRNA-Based Preservation Methods
• Innovations In siRNA Applications
• 6.12. Global Organ Preservation Solution Market, Sub-Segmentation Of Other Solution Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Experimental Preservation Solutions
• Emerging Organ Preservation Technologies

7. Organ Preservation Solution Market Regional And Country Analysis

• 7.1. Global Organ Preservation Solution Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Organ Preservation Solution Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Organ Preservation Solution Market

• 8.1. Asia-Pacific Organ Preservation Solution Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Organ Preservation Solution Market

• 9.1. China Organ Preservation Solution Market Overview
• 9.2. China Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Organ Preservation Solution Market

• 10.1. India Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Organ Preservation Solution Market

• 11.1. Japan Organ Preservation Solution Market Overview
• 11.2. Japan Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Organ Preservation Solution Market

• 12.1. Australia Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Organ Preservation Solution Market

• 13.1. Indonesia Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Organ Preservation Solution Market

• 14.1. South Korea Organ Preservation Solution Market Overview
• 14.2. South Korea Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Organ Preservation Solution Market

• 15.1. Western Europe Organ Preservation Solution Market Overview
• 15.2. Western Europe Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Organ Preservation Solution Market

• 16.1. UK Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Organ Preservation Solution Market

• 17.1. Germany Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Organ Preservation Solution Market

• 18.1. France Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Organ Preservation Solution Market

• 19.1. Italy Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Organ Preservation Solution Market

• 20.1. Spain Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Organ Preservation Solution Market

• 21.1. Eastern Europe Organ Preservation Solution Market Overview
• 21.2. Eastern Europe Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Organ Preservation Solution Market

• 22.1. Russia Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Organ Preservation Solution Market

• 23.1. North America Organ Preservation Solution Market Overview
• 23.2. North America Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Organ Preservation Solution Market

• 24.1. USA Organ Preservation Solution Market Overview
• 24.2. USA Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Organ Preservation Solution Market

• 25.1. Canada Organ Preservation Solution Market Overview
• 25.2. Canada Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Organ Preservation Solution Market

• 26.1. South America Organ Preservation Solution Market Overview
• 26.2. South America Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Organ Preservation Solution Market

• 27.1. Brazil Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Organ Preservation Solution Market

• 28.1. Middle East Organ Preservation Solution Market Overview
• 28.2. Middle East Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Organ Preservation Solution Market

• 29.1. Africa Organ Preservation Solution Market Overview
• 29.2. Africa Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Organ Preservation Solution Market Competitive Landscape And Company Profiles

• 30.1. Organ Preservation Solution Market Competitive Landscape
• 30.2. Organ Preservation Solution Market Company Profiles
  • 30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Accord Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. BioLife Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lifeline Scientific Overview, Products and Services, Strategy and Financial Analysis

31. Organ Preservation Solution Market Other Major And Innovative Companies

• 31.1. TransMedics Group Inc.
• 31.2. XVIVO Perfusion AB
• 31.3. Organ Recovery Systems Inc.
• 31.4. Bridge to Life Ltd.
• 31.5. Paragonix Technologies Inc.
• 31.6. OrganOx Limited
• 31.7. Shanghai Genext Pharmaceutical Technology
• 31.8. 21st Century Medicine
• 31.9. Institut Georges Lopez
• 31.10. Carnamedica
• 31.11. Global Transplant Solutions
• 31.12. Preservation Solutions Inc.
• 31.13. Essential Pharmaceuticals LLC
• 31.14. Dr. Franz Kohler Chemie GmbH
• 31.15. Advanced Organ Preservation Solutions (OPSL Group)

32. Global Organ Preservation Solution Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Organ Preservation Solution Market

34. Recent Developments In The Organ Preservation Solution Market

35. Organ Preservation Solution Market High Potential Countries, Segments and Strategies

• 35.1 Organ Preservation Solution Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Organ Preservation Solution Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Organ Preservation Solution Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer